Equipe labellisée par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Université de Paris Cité, Sorbonne Université, Institut Universitaire de France, Inserm U1138, Paris, France.
Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France.
Cancer Discov. 2022 Oct 5;12(10):2258-2279. doi: 10.1158/2159-8290.CD-22-0504.
In population studies, dietary patterns clearly influence the development, progression, and therapeutic response of cancers. Nonetheless, interventional dietary trials have had relatively little impact on the prevention and treatment of malignant disease. Standardization of nutritional interventions combined with high-level mode-of-action studies holds the promise of identifying specific entities and pathways endowed with antineoplastic properties. Here, we critically review the effects of caloric restriction and more specific interventions on macro- and micronutrients in preclinical models as well as in clinical studies. We place special emphasis on the prospect of using defined nutrition-relevant molecules to enhance the efficacy of established anticancer treatments.
The avoidance of intrinsically hypercaloric and toxic diets contributes to the prevention and cure of cancer. In addition, specific diet-induced molecules such as ketone bodies and micronutrients, including specific vitamins, have drug-like effects that are clearly demonstrable in preclinical models, mostly in the context of immunotherapies. Multiple trials are underway to determine the clinical utility of such molecules.
在人群研究中,饮食模式明显影响癌症的发展、进展和治疗反应。尽管如此,干预性饮食试验对恶性疾病的预防和治疗的影响相对较小。营养干预的标准化与高水平的作用机制研究相结合,有望确定具有抗肿瘤特性的特定实体和途径。在这里,我们批判性地回顾了热量限制和更具体的干预措施对临床前模型和临床研究中宏量和微量营养素的影响。我们特别强调使用特定的与营养相关的分子来增强既定抗癌治疗效果的前景。
避免内在高卡路里和有毒饮食有助于癌症的预防和治疗。此外,特定的饮食诱导分子,如酮体和微量营养素,包括特定的维生素,具有类似药物的作用,在临床前模型中得到了明确的证明,主要是在免疫治疗的背景下。正在进行多项试验以确定这些分子的临床实用性。